Search Results - "Zobniw, Chrystia M."

Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literature by Abdel-Wahab, Noha, Safa, Houssein, Abudayyeh, Ala, Johnson, Daniel H, Trinh, Van Anh, Zobniw, Chrystia M, Lin, Heather, Wong, Michael K, Abdelrahim, Maen, Gaber, A Osama, Suarez-Almazor, Maria E, Diab, Adi

“…Checkpoint inhibitors (CPIs) have revolutionized the treatment of cancer, but their use remains limited by off-target inflammatory and immune-related adverse…”
Get full text

Infliximab associated with faster symptom resolution compared with corticosteroids alone for the management of immune-related enterocolitis by Johnson, Daniel H, Zobniw, Chrystia M, Trinh, Van A, Ma, Junsheng, Bassett, Jr, Roland L, Abdel-Wahab, Noha, Anderson, Jaime, Davis, Jennifer E, Joseph, Jocelyn, Uemura, Marc, Noman, Ali, Abu-Sbeih, Hamzah, Yee, Cassian, Amaria, Rodabe, Patel, Sapna, Tawbi, Hussein, Glitza, Isabella C, Davies, Michael A, Wong, Michael K, Woodman, Scott, Hwu, Wen-Jen, Hwu, Patrick, Wang, Yinghong, Diab, Adi

“…Immune-related enterocolitis (irEC) is the most common serious complication from checkpoint inhibitors (CPIs). The current front-line treatment for irEC,…”
Get full text

Selective immune suppression using interleukin-6 receptor inhibitors for management of immune-related adverse events by Fa'ak, Faisal, Buni, Maryam, Falohun, Adewunmi, Lu, Huifang, Song, Juhee, Johnson, Daniel H, Zobniw, Chrystia M, Trinh, Van A, Awiwi, Muhammad Osama, Tahon, Nourel Hoda, Elsayes, Khaled M, Ludford, Kaysia, Montazari, Emma J, Chernis, Julia, Dimitrova, Maya, Sandigursky, Sabina, Sparks, Jeffrey A, Abu-Shawer, Osama, Rahma, Osama, Thanarajasingam, Uma, Zeman, Ashley M, Talukder, Rafee, Singh, Namrata, Chung, Sarah H, Grivas, Petros, Daher, May, Abudayyeh, Ala, Osman, Iman, Weber, Jeffrey, Tayar, Jean H, Suarez-Almazor, Maria E, Abdel-Wahab, Noha, Diab, Adi

“…BackgroundManagement of immune-related adverse events (irAEs) is important as they cause treatment interruption or discontinuation, more often seen with…”
Get full text

Olaratumab in the management of advanced soft tissue sarcoma by Zobniw, Chrystia M, Trinh, Van Anh, Posey, Kristi, Somaiah, Neeta

“…Olaratumab, the first-in-class anti-PDGFRα monoclonal antibody, has been contingently approved in combination with doxorubicin to treat adult patients with…”
Get full text

Corrections to: Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literature by Abdel-Wahab, Noha, Safa, Houssein, Abudayyeh, Ala, Johnson, Daniel H, Trinh, Van Anh, Zobniw, Chrystia M, Lin, Heather, Wong, Michael K, Abdelrahim, Maen, Gaber, A Osama, Suarez-Almazor, Maria E, Diab, Adi

“…Following publication of the original article [1], the authors reported an error in the Acknowledgments section. It should be read: 'We are grateful to Mohsin…”
Get full text

Correction to: Infliximab associated with faster symptom resolution compared with corticosteroids alone for the management of immune-related enterocolitis by Johnson, Daniel H, Zobniw, Chrystia M, Trinh, Van A, Ma, Junsheng, Bassett, Jr, Roland L, Abdel-Wahab, Noha, Anderson, Jaime, Davis, Jennifer E, Joseph, Jocelyn, Uemura, Marc, Noman, Ali, Abu-Sbeih, Hamzah, Yee, Cassian, Amaria, Rodabe, Patel, Sapna, Tawbi, Hussein, Glitza, Isabella C, Davies, Michael A, Wong, Michael K, Woodman, Scott, Hwu, Wen-Jen, Hwu, Patrick, Wang, Yinghong, Diab, Adi

“…Following publication of the original article [1], the authors reported an error in their listed affiliations…”
Get full text

Treatment patterns, efficacy and toxicity of regorafenib in gastrointestinal stromal tumour patients by Schvartsman, Gustavo, Wagner, Michael J., Amini, Behrang, Zobniw, Chrystia M., Trinh, Van Anh, Barbo, Andrea G., Lin, Heather Y., Wang, Wei-Lien, Conley, Anthony Paul, Ravi, Vinod, Araujo, Dejka M., Zarzour, Maria Alejandra, Benjamin, Robert S., Patel, Shreyaskumar, Somaiah, Neeta

“…Regorafenib was approved as third-line therapy for advanced Gastrointestinal Stromal Tumour (GIST) at a starting dose of 160 mg daily 3 weeks on, 1 week off,…”
Get full text

Bortezomib‐Induced Sweet's Syndrome Confirmed by Rechallenge by Zobniw, Chrystia M., Saad, Samira A., Kostoff, Diana, Barthel, Bernd G.

“…Sweet's syndrome, also known as acute febrile neutrophilic dermatosis, is characterized predominantly by fever, elevated neutrophil count, and erythematous…”
Get full text

Positive Tumor Response to Combined Checkpoint Inhibitors in a Patient With Refractory Alveolar Soft Part Sarcoma: A Case Report by Conley, Anthony P, Trinh, Van Anh, Zobniw, Chrystia M, Posey, Kristi, Martinez, Jaime D, Arrieta, Oscar G, Wang, Wei-Lien, Lazar, Alexander J, Somaiah, Neeta, Roszik, Jason, Patel, Shreyaskumar R

Get full text

An Unusual Case of Central Retinal Vein Occlusion and Review of the Toxicity Profile of Regorafenib in GIST Patients by Schvartsman, Gustavo, Wagner, Michael J., Zobniw, Chrystia M., Trinh, Van Anh, Patel, Shreyaskumar, Somaiah, Neeta

“…Gastrointestinal stromal tumor (GIST) is the most common sarcoma of the gastrointestinal tract with around 5000 new cases per year. Outcomes for patients with…”
Get full text

Clinical use of abiraterone in the treatment of metastatic castration-resistant prostate cancer by Zobniw, Chrystia M, Causebrook, Alanna, Fong, Mei Ka

“…Prostate cancer remains the most common type of cancer among men in the United States. Treatment for metastatic prostate cancer has improved significantly over…”
Get full text

Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response by Spencer, Christine N, McQuade, Jennifer L, Gopalakrishnan, Vancheswaran, McCulloch, John A, Vetizou, Marie, Cogdill, Alexandria P, Khan, Md A Wadud, Zhang, Xiaotao, White, Michael G, Peterson, Christine B, Wong, Matthew C, Morad, Golnaz, Rodgers, Theresa, Badger, Jonathan H, Helmink, Beth A, Andrews, Miles C, Rodrigues, Richard R, Morgun, Andrey, Kim, Young S, Roszik, Jason, Hoffman, Kristi L, Zheng, Jiali, Zhou, Yifan, Medik, Yusra B, Kahn, Laura M, Johnson, Sarah, Hudgens, Courtney W, Wani, Khalida, Gaudreau, Pierre-Olivier, Harris, Angela L, Jamal, Mohamed A, Baruch, Erez N, Perez-Guijarro, Eva, Day, Chi-Ping, Merlino, Glenn, Pazdrak, Barbara, Lochmann, Brooke S, Szczepaniak-Sloane, Robert A, Arora, Reetakshi, Anderson, Jaime, Zobniw, Chrystia M, Posada, Eliza, Sirmans, Elizabeth, Simon, Julie, Haydu, Lauren E, Burton, Elizabeth M, Wang, Linghua, Dang, Minghao, Clise-Dwyer, Karen, Schneider, Sarah, Chapman, Thomas, Anang, Nana-Ama A S, Duncan, Sheila, Toker, Joseph, Malke, Jared C, Glitza, Isabella C, Amaria, Rodabe N, Tawbi, Hussein A, Diab, Adi, Wong, Michael K, Patel, Sapna P, Woodman, Scott E, Davies, Michael A, Ross, Merrick I, Gershenwald, Jeffrey E, Lee, Jeffrey E, Hwu, Patrick, Jensen, Vanessa, Samuels, Yardena, Straussman, Ravid, Ajami, Nadim J, Nelson, Kelly C, Nezi, Luigi, Petrosino, Joseph F, Futreal, P Andrew, Lazar, Alexander J, Hu, Jianhua, Jenq, Robert R, Tetzlaff, Michael T, Yan, Yan, Garrett, Wendy S, Huttenhower, Curtis, Sharma, Padmanee, Watowich, Stephanie S, Allison, James P, Cohen, Lorenzo, Trinchieri, Giorgio, Daniel, Carrie R, Wargo, Jennifer A

“…Gut bacteria modulate the response to immune checkpoint blockade (ICB) treatment in cancer, but the effect of diet and supplements on this interaction is not…”
Get full text

Impact of pharmacists on identification of immune checkpoint inhibitor toxicities by Linger, Caitlin M., Trinh, Van A., Ma, Junsheng, Bassett, Roland, Zobniw, Chrystia M.

“…Background The use of novel immune checkpoint inhibitors (CPIs) has changed the face of management for cutaneous malignancies since their introduction. While…”
Get full text

Bortezomib-Induced Sweet's Syndrome Confirmed by Rechallenge by Zobniw, Chrystia M., Saad, Samira A., Kostoff, Diana, Barthel, Bernd G.

Get full text